Header Logo

Connection

LINGEGOWDA SELANERE MANGALA to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications LINGEGOWDA SELANERE MANGALA has written about Dose-Response Relationship, Drug.
LINGEGOWDA SELANERE MANGALA
Connection Strength
0.058
Dose-Response Relationship, Drug
  1. Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer. Oncotarget. 2017 Apr 18; 8(16):27380-27392.
    View in: PubMed
    Score: 0.020
  2. Cell killing and radiosensitizing effects of atorvastatin in PC3 prostate cancer cells. J Radiat Res. 2012; 53(2):225-33.
    View in: PubMed
    Score: 0.014
  3. EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma. Clin Cancer Res. 2010 May 01; 16(9):2562-70.
    View in: PubMed
    Score: 0.012
  4. Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma. Cancer Biol Ther. 2009 Aug; 8(16):1596-603.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.